Đang chuẩn bị liên kết để tải về tài liệu:
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Triple negative breast cancer (TNBC) is a distinct subtype of breast cancer burdened with a dismal prognosis due to the lack of effective therapeutic agents. Receptors for LHRH (luteinizing hormone-releasing hormone) can be successfully targeted with AEZS-108 [AN-152], an analog of LHRH conjugated to doxorubicin. |

TÀI LIỆU LIÊN QUAN

Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells

Local treatment for triple-negative breast cancer patients undergoing chemotherapy: Breast-conserving surgery or total mastectomy?

Breast cancer PAM50 signature: Correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.